📰 Haemonetics Co News
Haemonetics Co News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Haemonetics Co. Real-time updates on events, politics, business and more.
June 2, 2024
Eagle Asset Management Inc. raised its position in Haemonetics Co. (NYSE:HAE – Free Report) by 1.4% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 272,526 shares of the medical instruments supplier’s stock after purchasing an additional 3,883 shares during the period. Eagle Asset Management Inc. owned […]
June 1, 2024
Qtron Investments LLC increased its position in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 5.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,310 shares of the medical instruments supplier’s stock after acquiring an additional 343 shares during the quarter. Qtron […]
May 18, 2024
Jump Financial LLC acquired a new position in shares of Haemonetics Co. (NYSE:HAE – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund acquired 12,066 shares of the medical instruments supplier’s stock, valued at approximately $1,032,000. A number of other hedge funds have also bought and sold shares of HAE. Group One Trading […]
April 10, 2024
Peregrine Capital Management LLC trimmed its stake in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 14.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 110,313 shares of the medical instruments supplier’s stock after selling 18,094 shares during […]
April 10, 2024
Peregrine Capital Management LLC lowered its stake in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 14.1% in the fourth quarter, Holdings Channel.com reports. The firm owned 110,313 shares of the medical instruments supplier’s stock after selling 18,094 shares during the period. Peregrine Capital Management LLC’s holdings in Haemonetics were worth $9,433,000 as of […]
March 29, 2024
Haemonetics Co. (NYSE:HAE – Free Report) – Zacks Research lifted their Q1 2025 EPS estimates for shares of Haemonetics in a report issued on Thursday, March 28th. Zacks Research analyst R. Department now expects that the medical instruments supplier will post earnings of $0.94 per share for the quarter, up from their prior estimate of […]
February 10, 2024
Haemonetics Co. (NYSE:HAE – Get Free Report) gapped up prior to trading on Thursday after the company announced better than expected quarterly earnings. The stock had previously closed at $77.11, but opened at $81.26. Haemonetics shares last traded at $78.45, with a volume of 398,865 shares. The medical instruments supplier reported $1.04 EPS for the […]
January 28, 2024
Los Angeles Capital Management LLC lifted its position in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 1.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 53,058 shares of the medical instruments supplier’s stock after acquiring an additional 586 […]
January 27, 2024
Fifth Third Bancorp cut its position in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 79.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 393 shares of the medical instruments supplier’s stock after selling 1,555 shares during the period. Fifth Third Bancorp’s […]
January 27, 2024
California Public Employees Retirement System boosted its stake in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 53.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 167,782 shares of the medical instruments supplier’s stock after purchasing an […]